ClinicalTrials.Veeva

Menu

Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium (PRPITM)

I

Ibn Sina Hospital

Status

Completed

Conditions

Poor Endometrium

Treatments

Other: Treatment of Thin Endometrium

Study type

Interventional

Funder types

Other

Identifiers

NCT03166345
Ibnsina-Ganna-PRP

Details and patient eligibility

About

Platelets rich plasma is simple source of growth factors and cytokines that can regulate endometrial growth for subgroup of thin endometrium women. It is an autologous source of this enhancing factors; therefore, there os no risk of using it within the same participant.

Enrollment

150 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women with thin endometrium

Exclusion criteria

  • serum positive hepatitis B and C women

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

150 participants in 3 patient groups

PRP injection into Uterine Cavity
Experimental group
Description:
PRP injection into Uterine Cavity For Treatment of Thin Endometrium
Treatment:
Other: Treatment of Thin Endometrium
CSF (colony stimulating factor)
Experimental group
Description:
CSF for Treatment of Thin Endometrium
Treatment:
Other: Treatment of Thin Endometrium
No intervention
No Intervention group
Description:
The control arm.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems